LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | OSI-027 | 1.11 | uM | LJP6 | 3 | E09 | 72 | hr | 1097 | 1891 | 3769 | 0.5017 | 0.2970 |
BT-20 | XMD11-85h | 1.11 | uM | LJP6 | 1 | P21 | 72 | hr | 1097 | 2968 | 3769 | 0.7874 | 0.7001 |
BT-20 | XMD11-85h | 1.11 | uM | LJP6 | 2 | P21 | 72 | hr | 1097 | 3168 | 3769 | 0.8404 | 0.7749 |
BT-20 | XMD11-85h | 1.11 | uM | LJP6 | 3 | P21 | 72 | hr | 1097 | 3274 | 3769 | 0.8685 | 0.8146 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1097 | 2117 | 3769 | 0.5616 | 0.3816 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1097 | 2075 | 3769 | 0.5505 | 0.3659 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1097 | 1960 | 3769 | 0.5200 | 0.3229 |
BT-20 | WH-4-025 | 1.11 | uM | LJP5 | 1 | O09 | 72 | hr | 1097 | 1937 | 3769 | 0.5139 | 0.3142 |
BT-20 | WH-4-025 | 1.11 | uM | LJP5 | 2 | O09 | 72 | hr | 1097 | 2266 | 3769 | 0.6011 | 0.4374 |
BT-20 | WH-4-025 | 1.11 | uM | LJP5 | 3 | O09 | 72 | hr | 1097 | 1671 | 3769 | 0.4433 | 0.2147 |
BT-20 | WZ-4-145 | 1.11 | uM | LJP6 | 1 | J21 | 72 | hr | 1097 | 2136 | 3769 | 0.5667 | 0.3887 |
BT-20 | WZ-4-145 | 1.11 | uM | LJP6 | 2 | J21 | 72 | hr | 1097 | 2152 | 3769 | 0.5709 | 0.3947 |
BT-20 | WZ-4-145 | 1.11 | uM | LJP6 | 3 | J21 | 72 | hr | 1097 | 2245 | 3769 | 0.5956 | 0.4295 |
BT-20 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 1097 | 1428 | 3769 | 0.3788 | 0.1238 |
BT-20 | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 1097 | 1392 | 3769 | 0.3693 | 0.1103 |
BT-20 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 1097 | 1347 | 3769 | 0.3573 | 0.0935 |
BT-20 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1097 | 3382 | 3769 | 0.8972 | 0.8550 |
BT-20 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1097 | 3787 | 3769 | 1.0046 | 1.0065 |
BT-20 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 1097 | 3557 | 3769 | 0.9436 | 0.9205 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1097 | 1219 | 3769 | 0.3234 | 0.0456 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1097 | 1098 | 3769 | 0.2913 | 0.0003 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1097 | 1125 | 3769 | 0.2985 | 0.0104 |
BT-20 | BX-912 | 1.11 | uM | LJP5 | 1 | L21 | 72 | hr | 1097 | 3504 | 3769 | 0.9296 | 0.9006 |
BT-20 | BX-912 | 1.11 | uM | LJP5 | 2 | L21 | 72 | hr | 1097 | 3543 | 3769 | 0.9399 | 0.9152 |
BT-20 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1097 | 3812 | 3769 | 1.0113 | 1.0159 |